Regulation of the functional interaction between cyclin D1 and the estrogen receptor

被引:80
作者
Lamb, J
Ladha, MH
McMahon, C
Sutherland, RL
Ewen, ME
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Garvan Inst Med Res, Canc Res Program, Sydney, NSW 2010, Australia
关键词
D O I
10.1128/MCB.20.23.8667-8675.2000
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report that the functional interaction between cyclin D1 and the estrogen receptor (ER) is regulated by a signal transduction pathway involving the second messenger, cyclic AMP (cAMP). The cell-permeable cAMP analogue 8-bromo-cAMP caused a concentration-dependent enhancement of cyclin DI-ER complex formation, as judged both by coimmunoprecipitation and mammalian two-hybrid analysis. This effect was paralleled by increases in ligand-independent ER-mediated transcription from an estrogen response element containing reporter construct. These effects of 8-bromo-cAMP were antagonized by a specific protein kinase A (PKA) inhibitor, indicating that the signaling pathway involved was PKA dependent. Further, we show that culture of MCF-7 cells on a cellular substratum of murine preadipocytes also enhanced the functional interaction between cyclin D1 and ER in a PKA-dependent manner. These findings demonstrate a collaboration between cAMP signaling and cyclin D1 in the ligand-independent activation of ER-mediated transcription in mammary epithelial cells and show that the functional associations of cyclin D1 are regulated as a function of cellular context.
引用
收藏
页码:8667 / 8675
页数:9
相关论文
共 82 条
[1]  
AGGELER J, 1991, J CELL SCI, V99, P407
[2]   STIMULATION OF ESTROGEN RECEPTOR-MEDIATED TRANSCRIPTION AND ALTERATION IN THE PHOSPHORYLATION STATE OF THE RAT UTERINE ESTROGEN-RECEPTOR BY ESTROGEN, CYCLIC ADENOSINE-MONOPHOSPHATE, AND INSULIN-LIKE GROWTH FACTOR-I [J].
ARONICA, SM ;
KATZENELLENBOGEN, BS .
MOLECULAR ENDOCRINOLOGY, 1993, 7 (06) :743-752
[4]  
BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223
[5]   CYCLIN D1 PROTEIN EXPRESSION AND FUNCTION IN HUMAN BREAST-CANCER [J].
BARTKOVA, J ;
LUKAS, J ;
MULLER, H ;
LUTZHOFT, D ;
STRAUSS, M ;
BARTEK, J .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (03) :353-361
[6]   CDK-independent activities of D type cyclins [J].
Bernards, R .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1999, 1424 (2-3) :M17-M22
[7]   ASSOCIATION OF INT2/HST1 COAMPLIFICATION IN PRIMARY BREAST-CANCER WITH HORMONE-DEPENDENT PHENOTYPE AND POOR PROGNOSIS [J].
BORG, A ;
SIGURDSSON, H ;
CLARK, GM ;
FERNO, M ;
FUQUA, SAW ;
OLSSON, H ;
KILLANDER, D ;
MCGURIE, WL .
BRITISH JOURNAL OF CANCER, 1991, 63 (01) :136-142
[8]  
BUCKLEY MF, 1993, ONCOGENE, V8, P2127
[9]  
Chen DS, 1999, MOL CELL BIOL, V19, P1002
[10]   The p21Cip1 and p27Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts [J].
Cheng, MG ;
Olivier, P ;
Diehl, JA ;
Fero, M ;
Roussel, MF ;
Roberts, JM ;
Sherr, CJ .
EMBO JOURNAL, 1999, 18 (06) :1571-1583